HTA125 Ensuring Greater Acceptance of Minimal Residual Disease Negativity in Health Technology Assessments in Multiple Myeloma: Key Barriers and Opportunities
Abstract
Authors
AIKATERINI FAMELI
AIKATERINI FAMELI
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now